$Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study$

Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study

Purpose Sacubitril/valsartan has been associated with a positive reverse left ventricular remodelling in patients with heart failure with reduced ejection fraction (HFrEF). These patients may also benefit from an ICD implant. We aimed to assess EF improvement after 6 months of treatment with sacubit...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical pharmacology 2021-12, Vol.77 (12), p.1835-1842
Hauptverfasser:	Guerra, Federico, Ammendola, Ernesto, Ziacchi, Matteo, Aspromonte, Vittorio, Pellegrino, Pier Luigi, Del Giorno, Giuseppe, Dell’Era, Gabriele, Pimpini, Lorenzo, Santoro, Francesco, Floris, Roberto, Stronati, Giulia, Nigro, Gerardo, Paolisso, Pasquale, Guido, Alessandro, Maglia, Giampiero, Brunetti, Natale Daniele, Carbone, Angelo, Gravellone, Miriam, Antonicelli, Roberto, Cannone, Michele, Accogli, Michele, Dello Russo, Antonio, Palmisano, Pietro
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aminobutyrates - therapeutic use Biomedical and Life Sciences Biomedicine Biphenyl Compounds - therapeutic use Cardiomyopathy Clinical Trial Comorbidity Congestive heart failure Defibrillators Defibrillators, Implantable Drug Combinations Ejection fraction Female Heart failure Heart Failure - drug therapy Heart Failure - surgery Humans Ischemia Male Middle Aged Patients Pharmacology/Toxicology Prevention Prospective Studies Valsartan - therapeutic use Ventricle Ventricular Function, Left - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!